Business Description
CARsgen Therapeutics Holdings Ltd
ISIN : KYG1996C1006
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 21.71 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 15.3 | |||||
3-Year EPS without NRI Growth Rate | -27.3 | |||||
3-Year FCF Growth Rate | -11.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -10.22 | |||||
12-1 Month Momentum % | -10.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.55 | |||||
Quick Ratio | 9.54 | |||||
Cash Ratio | 9.43 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 5.65 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -34.34 | |||||
ROA % | -29.05 | |||||
ROIC % | -128.05 | |||||
ROC (Joel Greenblatt) % | -183.61 | |||||
ROCE % | -31.75 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.38 | |||||
Price-to-Tangible-Book | 1.39 | |||||
EV-to-EBIT | -0.81 | |||||
EV-to-EBITDA | -0.82 | |||||
EV-to-FCF | -1.3 | |||||
Price-to-Net-Current-Asset-Value | 1.76 | |||||
Price-to-Net-Cash | 1.78 | |||||
Earnings Yield (Greenblatt) % | -123.46 | |||||
FCF Yield % | -18.7 |